Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019

[1]  A. Duberg,et al.  Monitoring the progress towards the elimination of hepatitis B and C in Sweden: estimation of core indicators for 2015 and 2018 , 2022, BMC Infectious Diseases.

[2]  M. Ekstedt,et al.  Low awareness of non-alcoholic fatty liver disease in patients with type 2 diabetes in Swedish Primary Health Care , 2021, Scandinavian journal of gastroenterology.

[3]  H. El‐Serag,et al.  Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention , 2020, Nature Reviews Gastroenterology & Hepatology.

[4]  J. Jia,et al.  Regional variation and temporal trend of primary biliary cholangitis epidemiology: A systematic review and meta‐analysis , 2020, Journal of gastroenterology and hepatology.

[5]  E. Tapper,et al.  Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  J. Ludvigsson,et al.  Validity of administrative codes associated with cirrhosis in Sweden , 2020, Scandinavian journal of gastroenterology.

[7]  J. Ngu,et al.  Trends in Incidence of Autoimmune Liver Diseases and Increasing Incidence of Autoimmune Hepatitis. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  Z. Younossi,et al.  Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD , 2020, Hepatology.

[9]  A. Singal,et al.  Trends in Liver Disease Etiology Among Adults Awaiting Liver Transplantation in the United States, 2014-2019. , 2020, JAMA network open.

[10]  E. Björnsson,et al.  Increased incidence of autoimmune hepatitis is associated with wider use of biological drugs , 2019, Liver international : official journal of the International Association for the Study of the Liver.

[11]  Z. Younossi,et al.  The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis. , 2019, Journal of hepatology.

[12]  N. Björkström,et al.  Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis , 2019, Liver international : official journal of the International Association for the Study of the Liver.

[13]  N. Sattar,et al.  Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts , 2019, BMC Medicine.

[14]  V. Wong,et al.  Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[15]  P. Kamath,et al.  Burden of liver diseases in the world. , 2019, Journal of hepatology.

[16]  J. Lazarus,et al.  Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies. , 2018, Journal of hepatology.

[17]  P. Marcellin,et al.  Liver diseases: A major, neglected global public health problem requiring urgent actions and large‐scale screening , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[18]  M. Ekstedt,et al.  Natural History of NAFLD/NASH , 2017, Current Hepatology Reports.

[19]  Alan D. Lopez,et al.  The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level , 2017, JAMA oncology.

[20]  J. Ludvigsson,et al.  The Swedish cause of death register , 2017, European Journal of Epidemiology.

[21]  A. Törner,et al.  The underreporting of hepatocellular carcinoma to the cancer register and a log‐linear model to estimate a more correct incidence , 2017, Hepatology.

[22]  Robert Blissett,et al.  The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe , 2016, Hepatology.

[23]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[24]  S. Lindgren,et al.  Incidence, clinical presentation and mortality of liver cirrhosis in Southern Sweden: a 10‐year population‐based study , 2016, Alimentary pharmacology & therapeutics.

[25]  Mohsen Naghavi,et al.  Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis , 2014, BMC Medicine.

[26]  H. Vilstrup,et al.  Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. , 2014, Journal of hepatology.

[27]  J. Ludvigsson,et al.  External review and validation of the Swedish national inpatient register , 2011, BMC public health.

[28]  J. Ludvigsson,et al.  The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research , 2009, European Journal of Epidemiology.

[29]  L. Holmberg,et al.  The completeness of the Swedish Cancer Register – a sample survey for year 1998 , 2009, Acta oncologica.

[30]  L. Henry,et al.  NAFLD AND NASH: Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention , 2018 .